The NIH has scaled back its awards of new grants by at least $2.3 billion since the beginning of the year, a STAT analysis ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...

STAT reporters chat about pharma tariffs, the latest recovery in biotech stocks, and disappointing data from a Bristol Myers ...

A new study on Lyme disease sheds light on the persistence of symptoms; another new study points to an antibiotic that may be ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

A former FDA commissioner and a former Institute of Medicine president are teaming up to create the Vaccine Integrity Project ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

Harvard Medical School's finances are in a precarious place as it prepares for impending layoffs and sweeping cuts.

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

More than a dozen states are seeking federal permission to add work requirements to their Medicaid programs. Three states — ...

Last week, STAT’s Anil Oza reported that the Trump administration had targeted a scientific journal for its editorial ...